X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9394) 9394
Patent (1735) 1735
Book Review (403) 403
Conference Proceeding (329) 329
Book Chapter (191) 191
Newspaper Article (140) 140
Book / eBook (139) 139
Dissertation (131) 131
Magazine Article (115) 115
Publication (81) 81
Report (37) 37
Web Resource (18) 18
Trade Publication Article (17) 17
Government Document (9) 9
Music Score (4) 4
Newsletter (3) 3
Exam (2) 2
Microfilm (2) 2
Reference (2) 2
Video Recording (2) 2
Archival Material (1) 1
Map (1) 1
Paper (1) 1
Spoken Word Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2150) 2150
index medicus (1398) 1398
female (1241) 1241
male (1231) 1231
animals (618) 618
middle aged (602) 602
adult (587) 587
human necessities (584) 584
aged (521) 521
hygiene (504) 504
medical or veterinary science (500) 500
chemistry (489) 489
preparations for medical, dental, or toilet purposes (468) 468
physics (430) 430
metallurgy (422) 422
specific use of cosmetics or similar toiletpreparations (415) 415
performing operations (397) 397
transporting (397) 397
child (394) 394
analysis (375) 375
research (367) 367
electricity (338) 338
adolescent (321) 321
compositions based thereon (316) 316
organic macromolecular compounds (316) 316
their preparation or chemical working-up (316) 316
life sciences (289) 289
physics, applied (272) 272
heating (239) 239
risk factors (239) 239
lighting (237) 237
mechanical engineering (237) 237
weapons (233) 233
blasting (232) 232
general tagging of cross-sectional technologies spanning over several sections of the ipc (229) 229
general tagging of new technological developments (229) 229
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (229) 229
compositions of macromolecular compounds (228) 228
genetics & heredity (223) 223
child, preschool (219) 219
oncology (213) 213
immunology (209) 209
infant (206) 206
biochemistry & molecular biology (203) 203
mice (198) 198
pediatrics (198) 198
basic electric elements (196) 196
studies (193) 193
hematology (189) 189
mutation (187) 187
genetics (184) 184
health aspects (184) 184
disease (177) 177
genetic aspects (169) 169
children (168) 168
rats (168) 168
cancer (167) 167
cardiac & cardiovascular systems (167) 167
expression (165) 165
care and treatment (162) 162
aged, 80 and over (160) 160
chemistry, physical (158) 158
technical subjects covered by former uspc (157) 157
risk (154) 154
materials science, multidisciplinary (152) 152
treatment outcome (148) 148
pharmacology & pharmacy (146) 146
young adult (146) 146
multidisciplinary sciences (144) 144
diagnosis (142) 142
medicine (142) 142
prospective studies (140) 140
abridged index medicus (133) 133
retrospective studies (133) 133
proteins (131) 131
use of inorganic or non-macromolecular organic substances ascompounding ingredients (128) 128
usage (125) 125
optics (123) 123
physics, condensed matter (123) 123
astronomy & astrophysics (121) 121
cell biology (121) 121
epidemiology (121) 121
polymorphism, single nucleotide (121) 121
research article (120) 120
physics, atomic, molecular & chemical (118) 118
engineering, electrical & electronic (117) 117
microbiology (117) 117
phenotype (117) 117
mortality (116) 116
prognosis (116) 116
medicine, general & internal (115) 115
physiological aspects (114) 114
genome-wide association study (113) 113
genomes (113) 113
infectious diseases (113) 113
medicin och hälsovetenskap (113) 113
medical and health sciences (112) 112
chemotherapy (111) 111
engineering elements and units (109) 109
follow-up studies (109) 109
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (20) 20
Online Resources - Online (19) 19
UTL at Downsview - May be requested (8) 8
OISE - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Gerstein Science - Stacks (5) 5
Victoria University E.J. Pratt - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Media Commons - Microtexts (3) 3
Music - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Aerospace - Stacks (2) 2
Faculty of Information - Stacks (2) 2
Law (Bora Laskin) - Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Astronomy & Astrophysics - Ask at library (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Faculty of Information - May be requested in 6-10 wks (1) 1
Faculty of Information - Storage (1) 1
Gerstein Science - Theses (1) 1
Media Commons - Audio Visual (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Curriculum Resources (1) 1
OISE - Theses (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
Trinity College (John W Graham) - Oversize (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University Archives - Archives (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8159) 8159
French (5256) 5256
German (370) 370
Dutch (22) 22
Spanish (12) 12
Japanese (11) 11
Portuguese (9) 9
Italian (8) 8
Chinese (7) 7
Czech (2) 2
Danish (1) 1
Hungarian (1) 1
Latin (1) 1
Norwegian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
by Pogue, Janice and Riddle, Matthew C and Chazova, I and Gilbert, R and Gomis, R and Pīrāgs, V and Bogaty, P and Corson, M and Harper, W.L and Cukierman-Yaffee, T and MacRae, S and Alvarez, N and Amuchastegui, M and Bello, F and Caccavo, A and Calveira, M and Camino, A and Cardone, M and Corinaldesi, F and Crespo, C and Fares Taie, A and Fernandez, A and Ferrari, N and Gutierrez, N and Hasbani, E and Hrabar, A and Lobo Marquez, L and Lugo, M and Mainini, S and Manzano, R and Mendez, N and Odetto, I and Polari, P and Ramirez, A and Sanchez, R and Smith Casabella, T and Streitenberger, P and Villamil, A and Amerena, J and Farshid, A and Lefkovits, J and O'Neal, D and Poynten, A and Simpson, R and Teede, H and Tiong, F and Waddell-Smith, K and Blocher, J and Brath, H and Breuss, J and Jankovic, V and Kann, T and Placher-Sorko, G and Sonnenfeld, M and Vetter, B and Wallner, F and Lazareva, I and Delana, J and Feitosa, G and Garcia, V and Kanedlai, N and Mothe, F and Ninno, T and Oliveira, C and Oliveira, O and Roldan, F and Bailey, A and Belanger, A and Carlson, B and Chagnon, P and Chessex, C and Crepeau, J and Dube, F and Gosselin, G and Harper, W and Ho, K and Hramiak, I and Hutchinson, A and Langlois, M and Lavoie, M and Mercier, M and Nawaz, S and O'Keefe, D and Pruneau, G and Raby, K and Richard, C and Steinson, D and VanRossum, N and Warnica, W and Galloso, R and Stockins, B and Chen, Y and Gao, X and Ji, L and Jia, W and Li, Q and Li, Y and Ling, Y and Lu, B and Peng, Y and ... and unav and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3
Journal Article
by Bosch, Jackie and Riddle, Matthew C and Rydén, Lars E and Chazova, I and Gilbert, R and Gomis, R and Pīrāgs, V and Bogaty, P and Corson, M and Harper, W.L and Cukierman-Yaffee, T and MacRae, S and Alvarez, N and Amuchastegui, M and Bello, F and Caccavo, A and Calveira, M and Camino, A and Cardone, M and Corinaldesi, F and Crespo, C and Fares Taie, A and Fernandez, A and Ferrari, N and Gutierrez, N and Hasbani, E and Hrabar, A and Lobo Marquez, L and Lugo, M and Mainini, S and Manzano, R and Mendez, N and Odetto, I and Polari, P and Ramirez, A and Sanchez, R and Smith Casabella, T and Streitenberger, P and Villamil, A and Amerena, J and Farshid, A and Lefkovits, J and O'Neal, D and Poynten, A and Simpson, R and Teede, H and Tiong, F and Waddell-Smith, K and Blocher, J and Brath, H and Breuss, J and Jankovic, V and Kann, T and Placher-Sorko, G and Sonnenfeld, M and Vetter, B and Wallner, F and Lazareva, I and Delana, J and Feitosa, G and Garcia, V and Kanedlai, N and Mothe, F and Ninno, T and Oliveira, C and Oliveira, O and Roldan, F and Bailey, A and Belanger, A and Carlson, B and Chagnon, P and Chessex, C and Crepeau, J and Dube, F and Gosselin, G and Harper, W and Ho, K and Hramiak, I and Hutchinson, A and Langlois, M and Lavoie, M and Mercier, M and Nawaz, S and O'Keefe, D and Pruneau, G and Raby, K and Richard, C and Steinson, D and VanRossum, N and Warnica, W and Galloso, R and Stockins, B and Chen, Y and Gao, X and Ji, L and Jia, W and Li, Q and Li, Y and Ling, Y and Lu, B and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
MEDICINE, GENERAL & INTERNAL | EVENTS | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 14, pp. 1464 - 1476
Journal Article
by Walters, R. G and Jacquemont, S and Valsesia, A and de Smith, A. J and Martinet, D and Andersson, J and Falchi, M and Chen, F and Andrieux, J and Lobbens, S and Delobel, B and Stutzmann, F and El-Sayed Moustafa, J. S and Chèvre, J.-C and Lecoeur, C and Vatin, V and Bouquillon, S and Buxton, J. L and Boute, O and Holder-Espinasse, M and Cuisset, J.-M and Lemaitre, M.-P and Ambresin, A.-E and Brioschi, A and Gaillard, M and Giusti, V and Fellmann, F and Ferrarini, A and Hadjikhani, N and Campion, D and Guilmatre, A and Goldenberg, A and Calmels, N and Mandel, J.-L and Le Caignec, C and David, A and Isidor, B and Cordier, M.-P and Dupuis-Girod, S and Labalme, A and Sanlaville, D and Béri-Dexheimer, M and Jonveaux, P and Leheup, B and Õunap, K and Bochukova, E. G and Henning, E and Keogh, J and Ellis, R. J and MacDermot, K. D and van Haelst, M. M and Vincent-Delorme, C and Plessis, G and Touraine, R and Philippe, A and Malan, V and Mathieu-Dramard, M and Chiesa, J and Blaumeiser, B and Kooy, R. F and Caiazzo, R and Pigeyre, M and Balkau, B and Sladek, R and Bergmann, S and Mooser, V and Waterworth, D and Reymond, A and Vollenweider, P and Waeber, G and Kurg, A and Palta, P and Esko, T and Metspalu, A and Nelis, M and Elliott, P and Hartikainen, A.-L and McCarthy, M. I and Peltonen, L and Carlsson, L and Jacobson, P and Sjöström, L and Huang, N and Hurles, M. E and O’Rahilly, S and Farooqi, I. S and Männik, K and Jarvelin, M.-R and Pattou, F and Meyre, D and Walley, A. J and Coin, L. J. M and Blakemore, A. I. F and Froguel, P and Beckmann, J. S and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Nature (London), ISSN 1476-4687, 2010, Volume 463, Issue 7281, pp. 671 - 675
Journal Article